CVKD
Cadrenal Therapeutics, Inc.
1.20$
-4.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | |
| 93.5% | 99.7% | 99.9% | 99.8% | |
| 4.2% | 98.6% | 99.0% | 92.6% | |
| 4.2% | 98.6% | 99.0% | 92.6% | |
| – | 0.4% | 0.4% | 0.1% | |
| 5.7% | – | – | – | |
| 813.4% | 9.7% | 26.5% | 36.7% | |
| 171.5% | 9.7% | 26.5% | 36.7% | |
| 8.5% | 0.3% | – | – | |
| 52.0% | 2.0% | 14.8% | 15.0% | |
| 71.1% | – | – | – | |
| -713.4% | 90.3% | 73.5% | 63.3% | |
| -862.8% | -176.9% | -254.1% | -900.5% | |
| 99.7% | 10.2% | 12.0% | 46.1% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.